Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care

For much of the last three decades, treatment of degenerative knee disease has centered heavily on managing symptoms with anti-inflammatories, activity modification, lubricants and injections, while structural intervention was often reserved for more advanced disease. Focal cartilage defects had surgical options, but those came with their own tradeoffs in durability, complexity, and cost. That balance […]

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Grows Its Nevada Resource Base as Gold Reclaims Role as a Global Reserve Asset

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Gold miners with expanding resources and open mineralization are drawing fresh attention as investors look for ways to participate in a metal that is being redefined as a strategic reserve asset. That backdrop is exactly where Lahontan Gold (TSX.V: […]

BOXABL Inc. (NASDAQ: BXBL) Takes Factory-Built Construction Model into the Data Center Market

PAID ADVERTISEMENT. This article is a paid advertisement for BOXABL Inc. (Nasdaq: BXBL), distributed by NetworkNewsWire (“NNW”), a division of InvestorBrandNetwork (“IBN”). IBN has been compensated for advertising and digital media services related to BOXABL Inc. Readers should review the full disclaimer at the foot of this article before making any investment decision. BOXABL (NASDAQ: […]

Stocktoberfest 2026 ‘1-Day Pass’ Offers Access to Market Insights, Networking in NYC

Date: October 7, 2026 Venue: City Winery, New York City In its second year, leading investor social platform Stocktwits’ Stocktoberfest gathering is moving to the center of the financial universe — New York City — for its gathering of traders, investors, public company executives, financial professionals, and content creators, to generate real conversations that move […]

SS Innovations International Inc. (NASDAQ: SSII) Expands Robotic Cardiac Surgery Footprint with New Program at HCG Hospital in Ahmedabad

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital, Mithakhali, in Ahmedabad, India. The program began with a robotic cardiac surgery LIMA take-down performed using the SSi Mantra […]

Quantum BioPharma Ltd. (NASDAQ: QNTM) Receives FDA Green Light to Move Lucid-MS into Phase 2 Testing

A green light from the U.S. Food and Drug Administration (“FDA”) can turn years of laboratory work into a real shot at treating patients, and that is exactly what just happened for one biopharmaceutical company. Quantum BioPharma (NASDAQ: QNTM), a company focused on neurodegenerative and metabolic disorders, announced that the FDA has approved its Investigational […]

SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) Is ‘One to Watch’

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements. SuperQ Quantum Computing (CSE: QBTQ) (OTCQB: QBTQF) is a quantum and supercomputing company focused on reducing the technical and financial barriers to commercial adoption of advanced computing. The company combines quantum computing with classical high-performance computing to address complex optimization, cybersecurity and […]

 

From Our Blog

Regentis Biomaterials and the Shift from Symptom Management to Structural Repair in Knee Cartilage Care

September 28, 2026

For much of the last three decades, treatment of degenerative knee disease has centered heavily on managing symptoms with anti-inflammatories, activity modification, lubricants and injections, while structural intervention was often reserved for more advanced disease. Focal cartilage defects had surgical options, but those came with their own tradeoffs in durability, complexity, and cost. That balance […]

Rotate your device 90° to view site.